PCNA and acute lymphoblastic leukemia: In addition, cotreatment of apatinib and chidamide strikingly blunted cell proliferative ability in T-ALL in vivo, evidenced by diminished expressions of PCNA and Ki-67, two cell proliferative indexes (Figure 8C–E).